ClinicalTrials.gg
Not yet recruitingNCT07868783Updated Oct 9, 2026

Transcendental Meditation Intervention to Reduce Burnout and Enhance Resilience Among NewYork-Presbyterian Hospital and Weill Cornell Medicine Employees and Residents

An interventional study of Transcendental Meditation in Anxiety, Depression - Major Depressive Disorder and Burnout, sponsored by Weill Medical College of Cornell University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Weill Medical College of Cornell University · Not applicable, Interventional, and Prevention

Updated Oct 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to learn if a meditation intervention called Transcendental Meditation or TM can be used in a small department at Weill Cornell Medicine to help reduce employees' levels of burnout, anxiety, insomnia, and depression as well as to determine the feasibility and acceptability of the meditation practice by Weill Cornell employees. The main question the study aims to answer is whether:

  • Levels of burnout, anxiety, insomnia, and depression will be decreased, and overall mental well-being will improve over a 3.5-month period before and after TM intervention.

Participants will attend 9 sessions total (8 group sessions and 1 individual session) with a certified TM instructor from The David Lynch Foundation Institute for Mental Health and Resilience where they will gain experience in proper TM techniques. Also, participants will conduct 2 of their own TM sessions at home daily during the course of this study.

02

Conditions studied

  • Anxiety
  • Depression - Major Depressive Disorder
  • Burnout
  • Insomnia
  • Resilience
  • Feasibility
  • Acceptability

Keywords

  • Transcendental Meditation
  • TM
  • burnout
03

In context

Anxiety Disorders

5,063 studies on the registry are indexed under Anxiety Disorders; 1,408 are open to participants now.

This study's planned enrollment of 15 is below the median of 80 across 4,339 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Weill Medical College of Cornell University is the lead sponsor of 890 studies on the registry; 164 are open to participants now.

Of its 123 completed or terminated interventional studies of FDA-regulated products, 94 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be 18 years of age or older
  • Be a full-time employee at Weill Cornell Medicine or NewYork-Presbyterian Hospital.
  • Agree to complete the entire TM training program of eight sessions and practice the TM technique twice daily for approximately 20 minutes.
  • Agree to complete a battery of self-report baseline and post-test surveys online (1-month and 3-months post baseline).
  • If being treated with psychoactive medications, have maintained a stable regimen for at least two months prior to enrollment.
  • Can commit to remaining in the New York area for 3 ½ consecutive months (with the exception of brief trips, e.g., weekend trips) for the duration of the study period (baseline measures through 3-month post-testing).

Exclusion criteria

Exclusion Criteria:

  • Are younger than 18 years of age.
  • Are already instructed in the Transcendental Meditation technique.
  • Are not a full-time employee at Weill Cornell Medical College or NewYork-Presbyterian Hospital.
  • Are unwilling to complete the entire TM training program of eight sessions and practice the TM technique twice daily for approximately 20 minutes.
  • Are unwilling to complete a battery of self-report surveys online at baseline, at one month, and at three months post-baseline.
  • Have an unstable regimen of psychoactive medications in the past two months or psychiatric hospitalization in the last six months, per self-report.
  • Are unable to commit to remaining in the New York area for 3 ½ consecutive months (with the exception of brief trips, e.g., weekend trips) for the duration of the study period (baseline measures through 3-month post-testing).
  • This study will not include Adults unable to consent, Individuals who are not yet adults (infants, children, teenagers), and prisoners. The study may include pregnant women.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Transcendental Meditation

    Participants will undergo a TM training program of nine sessions and practice the TM technique twice daily for approximately 20 minutes

    Behavioral: Transcendental Meditation

Interventions

  • BehavioralTranscendental Meditation

    Participants will undergo a TM training program of nine sessions and practice the TM technique twice daily for approximately 20 minutes.The TM training program will include a total of 9 sessions conducted by experienced certified TM instructors: an introductory session (Session 0, described above), core instruction consisting of 4 sessions taught on 4 consecutive days (Sessions 1-4, 60-75 minutes each), followed by 4 follow-up sessions offered at intervals over the following 3 months (Sessions 5-8, 45 minutes each). All 9 sessions will be completed within 3.5 months from the time of the first session.

    Also known as: TM

06

What researchers measure

Primary outcomes

  1. Adherence to home practice of TM (1 month from baseline)

    Adherence to home TM practice will be assessed at 1 month post TM instruction, using a self-report form. Adherence to home TM practice will be the number of participants who responded that they did at least one home TM practice session per day on average out of all study participants. The self report survey asks participants over the past week and month how often they have done TM at home with three choices: 1) Twice a day, 2) Once a Day, and 3) Rarely or not at all. "Adherence" to home TM practice will be defined as at least one home TM practice session per day on average on this survey.

    Time frame: 1 month

  2. Adherence to home practice of TM (3 months from baseline)

    Adherence to home TM practice will be assessed at 3 month post TM instruction, using a self-report form. Adherence to home TM practice will be the number of participants who responded that they did at least one home TM practice session per day on average out of all study participants. The self report survey asks participants over the past week and month how often they have done TM at home with three choices: 1) Twice a day, 2) Once a Day, and 3) Rarely or not at all. "Adherence" to home TM practice will be defined as at least one home TM practice session per day on average on this survey.

    Time frame: 3 month

  3. Percentage of participants who attend 6 of the 8 training sessions over the course of the 3-month study

    Attendance at TM training sessions (feasibility) will be quantified as a binary outcome (either yes or no) based on whether at least 80% of the participants attend 6 of the 8 training sessions over the course of the 3 month study.

    Time frame: 3 months

  4. Change in Level of Anxiety from Baseline to 1 month

    Anxiety symptoms will be evaluated between baseline and 1 month with the Generalized Anxiety Disorder-7 (GAD-7) which is a brief 7-item anxiety questionnaire. The survey has 7 question prompts evaluating anxiety symptoms over the past 2 weeks and ranges from the lowest score of 0 to highest total score of 21. The highest score indicates severe anxiety while the lowest score indicates minimal anxiety.

    Time frame: baseline, 1 month

  5. Change in Level of Anxiety from Baseline to 3 months

    Anxiety symptoms will be evaluated between baseline and 3 months with the Generalized Anxiety Disorder-7 (GAD-7) which is a brief 7-item anxiety questionnaire . The survey has 7 question prompts evaluating anxiety symptoms over the past 2 weeks and ranges from the lowest score of 0 to highest total score of 21. The highest score indicates severe anxiety while the lowest score indicates minimal anxiety.

    Time frame: baseline, 3 months

  6. Change in Depression Score from Baseline to 1 Month

    The depression score will be measured by the NIH Promis Emotional Distress-Depression Short Form 6a. The survey has 6 questions prompts evaluating depression levels over the past week. The survey ranges from a lowest score of 0 indicating minimal to no depression and a highest score of 30 indicating severe depression. These surveys will evaluate change in depression from baseline to 1 month.

    Time frame: baseline, 1 month

  7. Change in Depression Score from Baseline to 3 Months

    The depression score will be measured by the NIH Promis Emotional Distress-Depression Short Form 6a. The survey has 6 questions prompts evaluating depression levels over the past week. The survey ranges from a lowest score of 0 indicating minimal to no depression and a highest score of 30 indicating severe depression. These surveys will evaluate change in depression from baseline to 3 months.

    Time frame: Baseline, 3 months

  8. Change in Burnout Score from Baseline to 1 Month

    Changes in feelings of burnout will be measured by the Maslach Burnout Inventory for Medical Personnel and will be assessed between baseline and 1 month. This survey has 22 question prompts related to how the employee feels from work related stress over the course of year. Respondents rate items on a frequency scale from 0 (Never) to 6 (Every day). The scores for the following three categories are added up independently: * Emotional Exhaustion (EE): 9 items summed to a range of 0 to 54. Higher scores mean greater emotional depletion while lower score indicate less emotional exhaustion * Depersonalization / Cynicism (DP): 5 items summed to a range of 0 to 30. Higher scores mean greater detachment and cynicism while lower scores indicate less detachment or cynicism * Personal Accomplishment (PA): 8 items summed to a range of 0 to 48. Lower scores indicate reduced professional efficacy and a higher risk of burnout while higher scores indicate less burnout risk and more accomplishment.

    Time frame: baseline, 1 month

  9. Change in Burnout Score from Baseline to 3 Months

    Changes in feelings of burnout will be measured by the Maslach Burnout Inventory for Medical Personnel and will be assessed between baseline and 1 month. This survey has 22 question prompts related to how the employee feels from work related stress over the course of year. Respondents rate items on a frequency scale from 0 (Never) to 6 (Every day). The scores for the following three categories are added up independently: * Emotional Exhaustion (EE): 9 items summed to a range of 0 to 54. Higher scores mean greater emotional depletion while lower score indicate less emotional exhaustion * Depersonalization / Cynicism (DP): 5 items summed to a range of 0 to 30. Higher scores mean greater detachment and cynicism while lower scores indicate less detachment or cynicism * Personal Accomplishment (PA): 8 items summed to a range of 0 to 48. Lower scores indicate reduced professional efficacy and a higher risk of burnout while higher scores indicate less burnout risk and greater accomplishment

    Time frame: Baseline, 3 months

  10. Change in Sleep Disturbance from Baseline to 1 Month

    Change in sleep disturbance between 1 month and baseline will be evaluated with the Insomnia Severity Index which has 7 question prompts. The survey ranges from a low score of 0 indicating no sleep disturbance to a maximum score of 28 indicating severe clinical insomnia.

    Time frame: baseline, 1 month

  11. Change in Sleep Disturbance from Baseline to 3 Month

    Change in sleep disturbance between 3 month and baseline will be evaluated with the Insomnia Severity Index which has 7 question prompts. The survey ranges from a low score of 0 indicating no sleep disturbance to a maximum score of 28 indicating severe clinical insomnia.

    Time frame: Baseline, 3 Months

Secondary outcomes

  1. Change Mental Well-Being from Baseline to 1 month

    Change in mental well-being between baseline and 1 month will measured by the Warwick-Edinburgh Mental Well-Being Scale which is a 14 item survey assessing feelings and thoughts regarding well-being over the past 2 weeks. The scores range from a low of 14 indicating very poor well being to a high of 70 indicating very good well being.

    Time frame: baseline, 1 month

  2. Change in Mental Well Being from Baseline to 3 Months

    Change in mental well-being between baseline and 3 months will measured by the Warwick-Edinburgh Mental Well-Being Scale which is a 14 item survey assessing feelings and thoughts regarding well-being over the past 2 weeks. The scores range from a low of 14 indicating very poor well being to a high of 70 indicating very good well being.

    Time frame: baseline, 3 month

  3. Change in Resilience Score from Baseline to 1 Month

    Resilience scores will be measured by the Brief Resilience Scale (BRS) at Baseline and 1 month and the change in scores calclulated. The BRS is a 6 item survey with scores ranging from a low of 6 to a high of 30. 6 indicates very low resilience and 30 superior resilience

    Time frame: baseline, 1 month

  4. Change in Resilience Score from Baseline to 3 Months

    Resilience scores will be measured by the Brief Resilience Scale (BRS) at Baseline and 3 months and the change in scores calclulated. The BRS is a 6 item survey with scores ranging from a low of 6 to a high of 30. 6 indicates very low resilience and 30 superior resilience

    Time frame: Baseline, 3 Months

07

Study locations

1 site
  • Weill Cornell Medicine, Starr Facility
    New York, New York 10065, United States
    • Valentina Marulanda-Corzo, MD · Contact · vam4009@med.cornell.edu · (646) 642 1917
    • Joseph Osborne, MD, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07868783
Collaborators
Institute for Mental Health and Resilience of the David Lynch Foundation
Responsible party
Sponsor
First posted
Oct 9, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Mar 15, 2027 (estimated)
Completion
Nov 27, 2027 (estimated)
Last update
Oct 9, 2026

Study contacts

Joseph Osborne, MD, PhD
Contact
jro7001@med.cornell.edu
(212) 746-6797
Valentina Marulanda-Corzo, MD
Contact
vam4009@med.cornell.edu
(646) 642 1917
Joseph Osborne, MD, PhD
principal investigator · Weill Cornell Medicine Department of Nuclear Medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion